| 000 | 01670 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517052041.0 | ||
| 264 | 0 | _c20161005 | |
| 008 | 201610s 0 0 eng d | ||
| 022 | _a1534-4681 | ||
| 024 | 7 |
_a10.1245/s10434-015-4856-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSmith, H G | |
| 245 | 0 | 0 |
_aIsolated Limb Perfusion with Melphalan and Tumour Necrosis Factor α for In-Transit Melanoma and Soft Tissue Sarcoma. _h[electronic resource] |
| 260 |
_bAnnals of surgical oncology _cDec 2015 |
||
| 300 |
_aS356-61 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Alkylating _xadministration & dosage |
| 650 | 0 | 4 |
_aChemotherapy, Cancer, Regional Perfusion _xmethods |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aExtremities |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLimb Salvage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMelanoma _xdrug therapy |
| 650 | 0 | 4 |
_aMelphalan _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aSarcoma _xdrug therapy |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xadministration & dosage |
| 700 | 1 | _aCartwright, J | |
| 700 | 1 | _aWilkinson, M J | |
| 700 | 1 | _aStrauss, D C | |
| 700 | 1 | _aThomas, J M | |
| 700 | 1 | _aHayes, A J | |
| 773 | 0 |
_tAnnals of surgical oncology _gvol. 22 Suppl 3 _gp. S356-61 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1245/s10434-015-4856-x _zAvailable from publisher's website |
| 999 |
_c25242227 _d25242227 |
||